UPM Institutional Repository

Peripheral analgesic effect of a novel curcuminoid derivative: possible involvement of peripheral opioid receptor and ATP-sensitive potassium ion channel


Citation

Lee, Ming Tatt and Ho, Yu Cheng and Tham, Chau Ling and Akira, Ahmad and Lajis, Nordin and Ahmad Israf, Daud and Sulaiman, Mohd Roslan (2026) Peripheral analgesic effect of a novel curcuminoid derivative: possible involvement of peripheral opioid receptor and ATP-sensitive potassium ion channel. Pharmaceutics, 18 (1). art. no. 141. pp. 1-13. ISSN 1999-4923

Abstract

Background/Objectives: The present study investigated the local analgesic effect of a novel synthetic cyclohexanone derivative, 2,6-bis-4-(hydroxyl-3-methoxybenzilidine)-cyclohexanone, or BHMC, in a mouse model of peripheral nociception. Methods: Local administration of BHMC (0.5–60 µg/paw) intra-plantarly in the hindpaws of mice exhibited significant inhibition in carrageenan-induced paw hyperalgesia. Intra-plantar pretreatment of naloxone (non-selective opioid receptor blocker), D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-ThrNH2 (CTOP, selective µ-opioid receptor blocker), and nor-binaltorphimine (nor-BNI, selective κ-opioid receptor blocker), but not naltrindole hydrochloride (selective δ-opioid receptor blocker), reversed the anti-nociceptive effect of BHMC. The peripheral analgesic effect of BHMC was also reversed by intra-plantar pretreatment of methylene blue (soluble guanosyl cyclase blocker), but not NG-nitro-L-arginine (L-NAME, nitric oxide synthase blocker). Involvement of the potassium channel in the local analgesic effect of BHMC was shown through the reversed analgesic effect by intra-plantar pretreatment of glibenclamide (ATP-sensitive potassium channel blocker), but not by charybdotoxin (large-conductance calcium-sensitive potassium channel blocker), apamin (small-conductance calcium-sensitive potassium ion channel blocker), or tetraethylammonium (voltage-sensitive potassium channel blocker). Results: Taken together, the present study demonstrated that the local administration of BHMC attenuated nociception, with possible mechanisms that may involve the desensitization of inflammatory mediators’ receptors, opioid receptor activation, and nitric oxide-independent cyclic guanosine monophosphate activation of ATP-sensitive potassium ion channel opening. Conclusions: The current findings may further support the exploration of BHMC as a new therapeutic agent for pain and inflammation, for the betterment of human health.


Download File

[img] Text
123679.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB)
Official URL or Download Paper: https://www.mdpi.com/1999-4923/18/1/141

Additional Metadata

Item Type: Article
Subject: Pharmaceutical Science
Divisions: Faculty of Medicine and Health Science
Institute of Bioscience
DOI Number: https://doi.org/10.3390/pharmaceutics18010141
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Keywords: Cyclic guanosyl monophosphate; Good health and well-being; Inflammatory mediators; Opioid receptor; Peripheral analgesia; Potassium ion channels
Depositing User: Mr. Mohamad Syahrul Nizam Md Ishak
Date Deposited: 16 Mar 2026 09:15
Last Modified: 16 Mar 2026 09:15
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.3390/pharmaceutics18010141
URI: http://psasir.upm.edu.my/id/eprint/123679
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item